Roche
340 Kingsland Street
Nutley
New Jersey
07110
United States
Tel: 973-235-5000
Fax: 973-235-7605
Website: http://www.roche.com/
About Roche
This site is no longer operational. Please visit Roche’s headquarters here.
Roche, founded in 1896, is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.
343 articles about Roche
-
Roche Share Discount Widens Speculation That Rival Novartis AG Will Sell Its $14.1 Billion Stake
12/18/2013
-
Ventana Medical Systems, Inc. Announces HER2 Companion Diagnostic To Identify Breast Cancer Patients For Roche's Latest Targeted Medicines, Perjeta And Kadcyla
12/13/2013
-
Roche Wins FDA Nod To Use Additional Specimen Types For Chlamydia And Gonorrhea Test
12/4/2013
-
Viriom Expands Global Licensing Agreement With Roche For Innovative Compound Development For HIV Treatment
11/20/2013
-
EU Clears Roche For Failing To Report Side Effects
11/19/2013
-
New Two-Hormone Roche Drug Shows Promise in Diabetes, Obesity
11/1/2013
-
Roche's Investigational Roactemra Subcutaneous Formulation Shows Comparable Long-Term Efficacy and Tolerability to the Intravenous Formulation in Rheumatoid Arthritis
10/28/2013
-
Roche Considers Moving Into Rare Disease Treatments
10/24/2013
-
Roche's Avastin Boosts Survival in Advanced Ovarian Cancer
10/23/2013
-
Roche Boosted by Strong Drug Sales in U.S. and China
10/17/2013
-
Drug Giant Roche to Lay Off More Workers From Its 454 Life Sciences Division
10/14/2013
-
National Institute for Clinical Excellence (NICE) Backs Roche's MabThera in Rare Autoimmune Disease
10/3/2013
-
Roche Updates Late-Stage Pipeline; Highlights Drugs Outside Core Cancer Focus
10/2/2013
-
Roche Open to Talks With Novartis AG
10/2/2013
-
Roche Readies $13.5 Billion Bid for BioMarin Pharmaceutical Inc., Not Alexion Pharmaceuticals Inc.
9/20/2013
-
FDA Approves Teva Pharmaceutical Industries Limited's Generic Version of Roche's Xeloda
9/17/2013
-
Roche's Perjeta Works in Early-Stage Breast Cancer
9/11/2013
-
Inovio Pharmaceuticals to Hold Investor Conference Call to Discuss Partnership With Roche
9/10/2013
-
Halozyme Therapeutics, Inc. Announces Roche Receives Marketing Authorization for Herceptin SC in European Union
9/3/2013
-
Roche Looks to Replicate Cancer Success With Eye Drugs
8/29/2013